General Announcement for PLC

19/02/2021

OTHERS UCREST BERHAD ("UCREST" OR "THE COMPANY") - CHANGE OF AUDITORS

UCREST BERHAD

Type Announcement
Subject OTHERS
Description
UCREST BERHAD ("UCREST" OR "THE COMPANY") - CHANGE OF AUDITORS

We refer to our announcement dated 10 February 2021 in relation to the resignation of Messrs CAS Malaysia PLT ("CAS") as Auditors of UCrest Berhad ("UCrest" or "the Company") for the financial year ending 31 May 2021.
The Board of Directors of UCrest ("the Board") wishes to announce that the Board had approved the Audit Committee's recommendation to appoint Messrs UHY as the new auditors of the Company for the financial year ending 31 May 2021. However, the appointment is subject to the following:-

1. The end of CAS's term of office which is twenty one (21) days from 10 February 2021 pursuant to Section 281(2) of the Companies Act 2016 ("the Act"); and

2. The Company receiving the written consent to act as Auditors of the Company from Messrs UHY pursuant to Section 264(5) of the Act.

Further announcement will be made by the Company once the Written Consent has been received.

The announcement is dated 19 February 2021.

 






Announcement Info

Company Name UCREST BERHAD
Stock Name UCREST
Date Announced 19 Feb 2021
Category General Announcement for PLC
Reference Number GA1-17022021-00056


Related Announcements for UCREST
Date Title
20/07/2022 OTHERS UCREST BERHAD ("UCREST" OR "THE COMPANY") - SERVICE LEVEL AGREEMENT WITH MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD
23/05/2022 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") - MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") ("MOU") - MASTER SERVICE AGREEMENT BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED ("UTL") AND LIMITED LIABILITY COMPANY HUMAN VACCINE ("HUMAN VACCINE"), A WHOLLY OWNED SUBSIDIARY OF RDIF ("MSA")
14/03/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING UCREST BERHAD ("UCREST") PRIVATE PLACEMENT OF NEW ORDINARY SHARES IN UCREST, PURSUANT TO THE GENERAL MANDATE OBTAINED FROM THE COMPANY'S SHAREHOLDERS ("PRIVATE PLACEMENT")
03/03/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING UCREST BERHAD ("UCREST") PRIVATE PLACEMENT OF NEW ORDINARY SHARES IN UCREST, PURSUANT TO THE GENERAL MANDATE OBTAINED FROM THE COMPANY'S SHAREHOLDERS ("PRIVATE PLACEMENT")
23/02/2022 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") - MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") ("MOU") - MASTER SERVICE AGREEMENT BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED AND LIMITED LIABILITY COMPANY HUMAN VACCINE, A WHOLLY OWNED SUBSIDIARY OF RDIF ("MSA")
30/11/2021 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") (I) MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") ("MOU") (II) MASTER SERVICE AGREEMENT BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED, AND LIMITED LIABILITY COMPANY HUMAN VACCINE, A WHOLLY OWNED SUBSIDIARY OF RDIF ("MSA")
26/11/2021 (I) MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") (II) MASTER SERVICE AGREEMENT BETWEEN UCREST BERHAD'S ("UCREST") WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED, AND LIMITED LIABILITY COMPANY HUMAN VACCINE, A WHOLLY OWNED SUBSIDIARY OF RDIF
24/11/2021 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") - MEMORANDUM OF UNDERSTANDING ("MOU") WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") - MASTER SERVICE AGREEMENT ("MSA") BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED ("UTL") AND LIMITED LIABILITY COMPANY HUMAN VACCINE ("HUMAN VACCINE"), A WHOLLY OWNED SUBSIDIARY OF RDIF
29/10/2021 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : DEALINGS DURING CLOSED PERIOD
01/10/2021 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : INTENTION TO DEAL DURING CLOSED PERIOD